SCM
DGX icon

Suvretta Capital Management’s Quest Diagnostics DGX Stock Holding History

Suvretta Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-357,835
Closed -$40.8M – 101
2020
Q2 		$40.8M Buy
+357,835
New +$38M 0.88% 40

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Suvretta Capital Management's DGX Position: Q3 2020 in Review

Suvretta Capital Management sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 357,835 shares — an estimated $40.8M sold.

Suvretta Capital Management first reported a position in DGX in Q2 2020 and held it in 1 quarter. The position peaked at $40.8M in Q2 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Suvretta Capital Management reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Suvretta Capital Management sold 357,835 Quest Diagnostics shares in Q3 2020, an estimated $40.8M.
  • Suvretta Capital Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 1 quarter.
  • Suvretta Capital Management's Quest Diagnostics position peaked at $40.8M in Q2 2020.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Suvretta Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.